Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers

2020 ◽  
Vol 184 (3) ◽  
pp. 655-663
Author(s):  
Sydney Marsh ◽  
Virginia F. Borges ◽  
Helen L. Coons ◽  
Anosheh Afghahi
SpringerPlus ◽  
2014 ◽  
Vol 3 (1) ◽  
Author(s):  
Paola Arnaboldi ◽  
Claudio Lucchiari ◽  
Luigi Santoro ◽  
Claudia Sangalli ◽  
Alberto Luini ◽  
...  

Author(s):  
AH Partridge ◽  
SM Rosenberg ◽  
PS Rajagopal ◽  
KJ Ruddy ◽  
RM Tamimi ◽  
...  

2014 ◽  
Vol 32 (26_suppl) ◽  
pp. 125-125 ◽  
Author(s):  
Hadeel Assad ◽  
Gauri Badhwar ◽  
Sameeksha Bhama ◽  
Cynthia Vakhariya ◽  
Judie R. Goodman

125 Background: Sexual dysfunction is a common and under acknowledged disorder in women with breast cancer. Sexual dysfunction in this scenario may be related to multiple factors: psychological distress due to diagnosis, physical decline due to treatment, change in hormonal milieu and/or poor body image. Methods: We assessed the changes in sexual activity after breast cancer diagnosis and treatment in 45 women using an anonymous questionnaire. Data was analyzed via descriptive statistics and paired sample t-test. Results: The age of women in our study ranged between 33-73 years with an average age of 51.6 years. Most of the subjects (89%) had completed chemotherapy and/or radiation therapy however 52% were still on hormonal treatment. Women who were more sexually active prior to breast cancer diagnosis were more likely to experience sexual dysfunction (p = 0.001). Overall, 45% of the women with breast cancer experienced a decline in their sexual health. A greater decline occurred after breast cancer treatment (chemotherapy and/or hormonal therapy) than after diagnosis (p < 0.05). Fifty percent had a decrease in libido and sexual arousal, 40.5% had difficulty in reaching sexual orgasm, and 29% had dyspareunia. Sexual difficulties were addressed by the treating oncologist in 3 out of the 45 women. Conclusions: The data reveals that sexual dysfunction is prevalent in breast cancer survivors. Its onset in concomitance with the diagnosis of breast cancer reflects the psychosocial impact of such a diagnosis. The further decline in sexual health after treatment emphasizes the important adverse effects of chemotherapy and hormone therapy in terms of vaginal dryness, dysparunia and sexual well-being. Despite its prevalence, sexual dysfunction is not commonly addressed in women with breast cancer. [Table: see text]


2014 ◽  
Vol 14 (6) ◽  
pp. 409-417 ◽  
Author(s):  
Menha Swellam ◽  
Hanan A. Soliman ◽  
Mohamed D.E. Abdelmaksoud ◽  
Amira M. Nageeb ◽  
Lobna R. Ezz El Arab ◽  
...  

2019 ◽  
Vol 177 (1) ◽  
pp. 207-214 ◽  
Author(s):  
Shoshana M. Rosenberg ◽  
Ines Vaz-Luis ◽  
Jingyi Gong ◽  
Padma Sheila Rajagopal ◽  
Kathryn J. Ruddy ◽  
...  

The Breast ◽  
2014 ◽  
Vol 23 (1) ◽  
pp. 50-55 ◽  
Author(s):  
Asma Ali ◽  
Karen Fergus ◽  
Frances C. Wright ◽  
Kathleen I. Pritchard ◽  
Alex Kiss ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document